ATE146179T1 - 27 hydroxyrapamycin und derivate davon - Google Patents

27 hydroxyrapamycin und derivate davon

Info

Publication number
ATE146179T1
ATE146179T1 AT93919994T AT93919994T ATE146179T1 AT E146179 T1 ATE146179 T1 AT E146179T1 AT 93919994 T AT93919994 T AT 93919994T AT 93919994 T AT93919994 T AT 93919994T AT E146179 T1 ATE146179 T1 AT E146179T1
Authority
AT
Austria
Prior art keywords
hydroxyrapamycin
derivatives
formula
compound
deoxo
Prior art date
Application number
AT93919994T
Other languages
German (de)
English (en)
Inventor
Frances Christy Nelson
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/009,605 external-priority patent/US5256790A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE146179T1 publication Critical patent/ATE146179T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT93919994T 1992-08-13 1993-08-12 27 hydroxyrapamycin und derivate davon ATE146179T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93012492A 1992-08-13 1992-08-13
US08/009,605 US5256790A (en) 1992-08-13 1993-01-27 27-hydroxyrapamycin and derivatives thereof

Publications (1)

Publication Number Publication Date
ATE146179T1 true ATE146179T1 (de) 1996-12-15

Family

ID=26679675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93919994T ATE146179T1 (de) 1992-08-13 1993-08-12 27 hydroxyrapamycin und derivate davon

Country Status (12)

Country Link
EP (1) EP0655065B1 (enExample)
JP (1) JPH08501084A (enExample)
AT (1) ATE146179T1 (enExample)
AU (1) AU5007193A (enExample)
CA (1) CA2142288A1 (enExample)
DE (1) DE69306585T2 (enExample)
DK (1) DK0655065T3 (enExample)
ES (1) ES2096941T3 (enExample)
GR (1) GR3022730T3 (enExample)
HU (1) HU221499B (enExample)
MX (1) MX9304868A (enExample)
WO (1) WO1994004540A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
EP0729471A1 (en) * 1993-11-19 1996-09-04 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
KR100400620B1 (ko) * 1995-06-09 2004-02-18 노파르티스 아게 라파마이신유도체
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
ES2219388T3 (es) 1999-08-24 2004-12-01 Ariad Gene Therapeutics, Inc. 28-epi-rapalogos.
JP4547911B2 (ja) * 2002-02-01 2010-09-22 アリアド・ファーマシューティカルズ・インコーポレイテッド リン含有化合物およびその用途
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
AU2007319825B2 (en) 2006-11-14 2014-01-23 Ariad Pharmaceuticals, Inc. Oral formulations
EP2245165A4 (en) 2008-01-11 2011-06-01 Massachusetts Eye & Ear Infirm TRANSGENIC CONDITIONAL STOP DIMERICABLE CASPASE ANIMALS
EP4491726A3 (en) 2013-06-11 2025-03-05 Takara Bio USA, Inc. Protein enriched microvesicles and methods of making and using the same
MX2020011564A (es) 2018-05-01 2021-01-29 Revolution Medicines Inc Analogos de rapamicina unidos a c26 como inhibidores de mtor.
HRP20230488T1 (hr) 2018-05-01 2023-08-04 Revolution Medicines, Inc. C40-, C28- I C-32-VEZANI ANALOZI RAPAMICINA KAO INHIBITORI mTOR
WO2022216900A2 (en) * 2021-04-09 2022-10-13 Revolution Medicines, Inc. Synthesis of rapamycin analog compounds
US12539305B2 (en) 2022-05-25 2026-02-03 Revolution Medicines, Inc. Methods of treating cancer with an mTOR inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04230389A (ja) * 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
US5102876A (en) * 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin

Also Published As

Publication number Publication date
HU9500432D0 (en) 1995-04-28
GR3022730T3 (en) 1997-06-30
EP0655065A1 (en) 1995-05-31
EP0655065B1 (en) 1996-12-11
CA2142288A1 (en) 1994-03-03
ES2096941T3 (es) 1997-03-16
DE69306585D1 (de) 1997-01-23
DE69306585T2 (de) 1997-04-17
DK0655065T3 (enExample) 1997-02-24
HU221499B (en) 2002-10-28
MX9304868A (es) 1994-05-31
JPH08501084A (ja) 1996-02-06
AU5007193A (en) 1994-03-15
WO1994004540A1 (en) 1994-03-03
HUT71614A (en) 1996-01-29

Similar Documents

Publication Publication Date Title
DE69306585D1 (de) 27 hydroxyrapamycin und derivate davon
ES2085726T3 (es) Derivado prolinico de rapamicina, su produccion y aplicacion.
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
NO932873D0 (no) 9-((substituerte glycyl)amido)-6-dementyl-6-deoksotetrasykliner
ATE180773T1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
BG92804A (bg) 4-бензоилизоксазолови производни
DE69428142D1 (de) Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung
NO904187L (no) Benzanilider.
DE69423339D1 (de) Epoxycyclohexendionderivat
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DK377687D0 (da) Triazol-fungicidpraeparater
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
DE69220222D1 (de) Neue D-Homo-17-oxa und D-Homo-17-aza-androstanderivate
DE69601451D1 (de) UCK14-Verbindungen
ATE255121T1 (de) Antitumor-indolopyrolocarbazolderivat
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
ATE138382T1 (de) Antitumor- und antivirale-verbindung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee